Trademark: 88083922
Word
MOJAGRI
Status
Registered
Status Code
700
Status Date
Tuesday, October 1, 2019
Serial Number
88083922
Registration Number
5871306
Registration Date
Tuesday, October 1, 2019
Mark Type
4000
Filing Date
Sunday, August 19, 2018
Published for Opposition
Tuesday, July 16, 2019

Trademark Owner History
MorphoSys AG - Original Registrant

Classifications
5 Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis
42 Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies

Trademark Events
Oct 1, 2019
Registered-Principal Register
Jul 16, 2019
Official Gazette Publication Confirmation E-Mailed
Jul 16, 2019
Published For Opposition
Jun 26, 2019
Notification Of Notice Of Publication E-Mailed
Jun 12, 2019
Approved For Pub - Principal Register
Jun 10, 2019
Examiner's Amendment Entered
Jun 10, 2019
Notification Of Examiners Amendment E-Mailed
Jun 10, 2019
Examiners Amendment E-Mailed
Jun 10, 2019
Examiners Amendment -Written
Jun 3, 2019
Teas/Email Correspondence Entered
Jun 3, 2019
Correspondence Received In Law Office
May 31, 2019
Teas Response To Office Action Received
Dec 4, 2018
Notification Of Non-Final Action E-Mailed
Dec 4, 2018
Non-Final Action E-Mailed
Dec 4, 2018
Non-Final Action Written
Nov 28, 2018
Assigned To Examiner
Oct 16, 2018
Applicant Amendment Prior To Examination - Entered
Oct 15, 2018
Assigned To Lie
Sep 30, 2018
Teas Voluntary Amendment Received
Aug 27, 2018
New Application Office Supplied Data Entered In Tram
Aug 22, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24